OFI Advisors’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
$322K Sell
7,125
-392
-5% -$18.5K 0.02% 954
2015
Q2
$348K Sell
7,517
-528
-7% -$23.1K 0.02% 966
2015
Q1
$345K Sell
8,045
-563
-7% -$21.5K 0.02% 957
2014
Q4
$299K Sell
8,608
-271
-3% -$8.99K 0.02% 997
2014
Q3
$287K Buy
8,879
+463
+6% +$15.5K 0.02% 961
2014
Q2
$285K Sell
8,416
-926
-10% -$29.7K 0.02% 970
2014
Q1
$255K Buy
9,342
+2,382
+34% +$70.8K 0.02% 977
2013
Q4
$249K Buy
6,960
+1,430
+26% +$47.5K 0.02% 962
2013
Q3
$167K Buy
5,530
+1,105
+25% +$36.1K 0.02% 1074
2013
Q2
$129K Buy
+4,425
New +$125K 0.01% 1126

Other funds holding PBH

OFI Advisors's PBH Position: Q3 2015 in Review

OFI Advisors reduced its Prestige Consumer Healthcare (PBH) stake by 5.2% in Q3 2015, selling an estimated $18.5K and leaving 7,125 shares worth $322K. The position accounts for 0.02% of the portfolio, ranked #954.

OFI Advisors first reported a position in PBH in Q2 2013 and has held it in 10 quarters since. The position peaked at $348K in Q2 2015. 206 funds tracked by Wall St. Rank hold PBH as of Q3 2015.

  • OFI Advisors held 7,125 shares of Prestige Consumer Healthcare worth $322K as of Q3 2015.
  • OFI Advisors sold 392 Prestige Consumer Healthcare shares in Q3 2015, an estimated $18.5K.
  • Prestige Consumer Healthcare made up 0.02% of OFI Advisors's portfolio in Q3 2015, its #954 holding.
  • OFI Advisors first reported a position in Prestige Consumer Healthcare in Q2 2013 and has held it in 10 quarters since.
  • OFI Advisors's Prestige Consumer Healthcare position peaked at $348K in Q2 2015.
  • 206 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q3 2015.

Based on OFI Advisors's 13F filing for Q3 2015, filed 13 Nov 2015.